Is Nutriband Stock a Good Investment?
Nutriband Investment Advice | NTRB |
- Examine Nutriband's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Nutriband's leadership team and their track record. Good management can help Nutriband navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Nutriband's business and its evolving consumer preferences.
- Compare Nutriband's performance and market position to its competitors. Analyze how Nutriband is positioned in terms of product offerings, innovation, and market share.
- Check if Nutriband pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Nutriband's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Nutriband stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Nutriband is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | OK | Details | |
Volatility | Unstable | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Nutriband Stock
Researching Nutriband's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 54.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.71. Nutriband last dividend was issued on the 24th of July 2019. The entity had 1166:1000 split on the 12th of August 2022.
To determine if Nutriband is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Nutriband's research are outlined below:
Nutriband is way too risky over 90 days horizon | |
Nutriband appears to be risky and price may revert if volatility continues | |
The company reported the previous year's revenue of 2.09 M. Net Loss for the year was (5.49 M) with profit before overhead, payroll, taxes, and interest of 804.61 K. | |
Nutriband currently holds about 3.34 M in cash with (3.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.43. | |
Roughly 54.0% of the company outstanding shares are owned by corporate insiders | |
Latest headline from simplywall.st: Breakeven On The Horizon For Nutriband Inc. |
Nutriband Quarterly Cash And Short Term Investments |
|
Nutriband uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Nutriband. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Nutriband's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
24th of April 2024 Upcoming Quarterly Report | View | |
14th of June 2024 Next Financial Report | View | |
31st of January 2024 Next Fiscal Quarter End | View | |
24th of April 2024 Next Fiscal Year End | View | |
31st of October 2023 Last Quarter Report | View | |
31st of January 2023 Last Financial Announcement | View |
Earnings surprises can significantly impact Nutriband's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Nutriband's investors have experienced.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2021-06-14 | 2021-04-30 | -0.05 | -0.04 | 0.01 | 20 | ||
2022-05-31 | 2022-04-30 | -0.06 | -0.08 | -0.02 | 33 | ||
2020-12-15 | 2020-10-31 | -0.03 | -0.01 | 0.02 | 66 | ||
2020-09-11 | 2020-07-31 | -0.06 | -0.03 | 0.03 | 50 | ||
2023-09-11 | 2023-07-31 | -0.07 | -0.1059 | -0.0359 | 51 | ||
2022-09-08 | 2022-07-31 | -0.07 | -0.12 | -0.05 | 71 | ||
2023-06-09 | 2023-04-30 | -0.06 | -0.1296 | -0.0696 | 116 | ||
2020-04-14 | 2020-01-31 | -0.08 | -0.15 | -0.07 | 87 |
Know Nutriband's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Nutriband is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nutriband backward and forwards among themselves. Nutriband's institutional investor refers to the entity that pools money to purchase Nutriband's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Bank Of America Corp | 130 | Jpmorgan Chase & Co | 2024-12-31 | 12.0 | Blackrock Inc | 2024-09-30 | 0.0 | Atria Wealth Solutions, Inc. | 2024-12-31 | 0.0 | Creative Financial Designs Inc | 2024-12-31 | 0.0 | Millennium Management Llc | 2024-09-30 | 0.0 | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 0.0 | Hrt Financial Llc | 2024-12-31 | 0.0 | Vanguard Group Inc | 2024-12-31 | 124.6 K | Geode Capital Management, Llc | 2024-12-31 | 62.4 K | State Street Corp | 2024-12-31 | 17.3 K |
Nutriband's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 109.95 M.Market Cap |
|
Nutriband's profitablity analysis
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (2.70) | (2.84) | |
Return On Capital Employed | (0.67) | (0.71) | |
Return On Assets | (0.66) | (0.69) | |
Return On Equity | (0.77) | (0.81) |
Determining Nutriband's profitability involves analyzing its financial statements and using various financial metrics to determine if Nutriband is a good buy. For example, gross profit margin measures Nutriband's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Nutriband's profitability and make more informed investment decisions.
Please note, the presentation of Nutriband's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Nutriband's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Nutriband's management manipulating its earnings.
Evaluate Nutriband's management efficiency
Nutriband has return on total asset (ROA) of (0.3013) % which means that it has lost $0.3013 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6041) %, meaning that it created substantial loss on money invested by shareholders. Nutriband's management efficiency ratios could be used to measure how well Nutriband manages its routine affairs as well as how well it operates its assets and liabilities. As of March 20, 2025, Return On Tangible Assets is expected to decline to -2.84. In addition to that, Return On Capital Employed is expected to decline to -0.71. At present, Nutriband's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 11.6 K, whereas Total Assets are forecasted to decline to about 5.5 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 0.73 | 0.42 | |
Tangible Book Value Per Share | 0.08 | 0.06 | |
Enterprise Value Over EBITDA | (3.60) | (3.78) | |
Price Book Value Ratio | 2.90 | 3.05 | |
Enterprise Value Multiple | (3.60) | (3.78) | |
Price Fair Value | 2.90 | 3.05 | |
Enterprise Value | 23.6 M | 35.3 M |
The strategic initiatives led by Nutriband's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Beta 0.416 |
Basic technical analysis of Nutriband Stock
As of the 20th of March, Nutriband secures the Downside Deviation of 6.34, risk adjusted performance of 0.0932, and Mean Deviation of 6.32. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nutriband, as well as the relationship between them.Nutriband's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nutriband insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nutriband's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nutriband insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Gareth Sheridan over three months ago Disposition of 1000000 shares by Gareth Sheridan of Nutriband at 0.001 subject to Rule 16b-3 | ||
Serguei Melnik over six months ago Disposition of tradable shares by Serguei Melnik of Nutriband subject to Rule 16b-3 | ||
Serguei Melnik over six months ago Disposition of 20000 shares by Serguei Melnik of Nutriband subject to Rule 16b-3 | ||
Serguei Melnik over six months ago Acquisition by Serguei Melnik of 20000 shares of Nutriband at 5.34 subject to Rule 16b-3 |
Nutriband's Outstanding Corporate Bonds
Nutriband issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Nutriband uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Nutriband bonds can be classified according to their maturity, which is the date when Nutriband has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
OCPMR 5125 23 JUN 51 Corp BondUS67091TAE55 | View | |
OCPMR 375 23 JUN 31 Corp BondUS67091TAD72 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand Nutriband's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Nutriband's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
Risk Adjusted Performance | 0.0932 | |||
Market Risk Adjusted Performance | 0.5154 | |||
Mean Deviation | 6.32 | |||
Semi Deviation | 5.99 | |||
Downside Deviation | 6.34 | |||
Coefficient Of Variation | 1046.98 | |||
Standard Deviation | 9.58 | |||
Variance | 91.77 | |||
Information Ratio | 0.1046 | |||
Jensen Alpha | 1.08 | |||
Total Risk Alpha | 1.96 | |||
Sortino Ratio | 0.158 | |||
Treynor Ratio | 0.5054 | |||
Maximum Drawdown | 54.72 | |||
Value At Risk | (9.34) | |||
Potential Upside | 17.09 | |||
Downside Variance | 40.21 | |||
Semi Variance | 35.94 | |||
Expected Short fall | (7.62) | |||
Skewness | 2.03 | |||
Kurtosis | 6.15 |
Risk Adjusted Performance | 0.0932 | |||
Market Risk Adjusted Performance | 0.5154 | |||
Mean Deviation | 6.32 | |||
Semi Deviation | 5.99 | |||
Downside Deviation | 6.34 | |||
Coefficient Of Variation | 1046.98 | |||
Standard Deviation | 9.58 | |||
Variance | 91.77 | |||
Information Ratio | 0.1046 | |||
Jensen Alpha | 1.08 | |||
Total Risk Alpha | 1.96 | |||
Sortino Ratio | 0.158 | |||
Treynor Ratio | 0.5054 | |||
Maximum Drawdown | 54.72 | |||
Value At Risk | (9.34) | |||
Potential Upside | 17.09 | |||
Downside Variance | 40.21 | |||
Semi Variance | 35.94 | |||
Expected Short fall | (7.62) | |||
Skewness | 2.03 | |||
Kurtosis | 6.15 |
Consider Nutriband's intraday indicators
Nutriband intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Nutriband stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Nutriband Corporate Filings
13th of March 2025 Other Reports | ViewVerify | |
8K | 13th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
16th of December 2024 Other Reports | ViewVerify | |
10Q | 4th of December 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Nutriband Stock media impact
Far too much social signal, news, headlines, and media speculation about Nutriband that are available to investors today. That information is available publicly through Nutriband media outlets and privately through word of mouth or via Nutriband internal channels. However, regardless of the origin, that massive amount of Nutriband data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Nutriband news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Nutriband relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Nutriband's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Nutriband alpha.
Nutriband Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Nutriband can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
When determining whether Nutriband offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nutriband's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nutriband Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nutriband Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nutriband. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Nutriband Stock refer to our How to Trade Nutriband Stock guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nutriband. If investors know Nutriband will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nutriband listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.71) | Revenue Per Share | Quarterly Revenue Growth (0.14) | Return On Assets | Return On Equity |
The market value of Nutriband is measured differently than its book value, which is the value of Nutriband that is recorded on the company's balance sheet. Investors also form their own opinion of Nutriband's value that differs from its market value or its book value, called intrinsic value, which is Nutriband's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nutriband's market value can be influenced by many factors that don't directly affect Nutriband's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Nutriband's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Nutriband is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nutriband's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.